Liabilities / Assets
82nd percentile
Higher debt load relative to assets than 82% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.51x
Liabilities / Revenue
77th percentile
Higher debt load relative to revenue than 77% of similar nonprofits.
Net Margin
66th percentile
Higher net margin than 66% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
88th percentile
Faster asset growth than 88% of similar nonprofits.
Revenue Growth
98th percentile
Faster revenue growth than 98% of similar nonprofits.
Balance Sheet
Assets
Up$507,373
Up $148,291 (+41%) from 2011
Net Assets
Up$251,134
Up $77,401 (+45%) from 2011
Liabilities
Up$256,239
Up $70,890 (+38%) from 2011
Revenue And Expenses
Revenue
Up$858,881
Up $666,984 (+348%) from 2011
Expenses
Up$781,480
Up $582,624 (+293%) from 2011
Net Income
Up$77,401
Up $84,360 (+1212%) from 2011
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview
Mission
All activities for research and treatment of Cystic Fibrosis.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $507,373
- Liabilities
- $256,239
- Net assets
- $251,134
- Revenue
- $858,881
- Expenses
- $781,480
- Net income
- $77,401